retatrutide 20 mg vial 20mg Retatrutide — 20mg – Peptidic.

But GLP ones being used in people who are not overweight, but they have PCOS because mechanistically, we know that roughly 70% of those with PCOS have insulin resistance

This subcutaneous injectable form ensures efficient absorption and faster action compared to oral supplements, which are often broken down and poorly absorbed by the digestive system

Long-acting dosage forms have more advantages in blood sugar control due to their longer half-life and stable blood concentration

Back Phelan, M (30 May 2024) 'Winning researchers unlocked GLP-1 drugs for obesity', Science , 384/6699

Both medications can suppress appetite , leading to potential risks of undernutrition

Conversely, patients with diarrhoea should maintain hydration and may benefit from temporarily reducing fibre intake whilst symptoms persist